Analysis of factors of hepatic function in patients with ankylosing spondylitis

ZHANG Qing,BAO Jun,XU Huji
2009-01-01
Abstract:Objective To analyze the disease activity of patients with ankylosing spondylitis(AS)and the influence of medication on hepatic function.Methods Totally 110 patients with AS were divided into different groups according to the activity of AS and drug treatment,and then the hepatic functions were analyzed in different groups.Results The man to woman ratio in our groups was 6∶1.The peak time of disease onset was at the age of 20~40,follow by those younger than 20 years old.The incidence of hepatic dysfunction in the patients at active phase was significantly higher than that in those at stable phase(32.6% vs.24.1%,P<0.05).The incidences of hepatic dysfunction were comparable among patients treated with nonsteroidal antiinflammatory drugs(NSAIDs,8.2%),Sulfasalazine(SSZ,6.3%),or methotrexate(MTX,4.7%,all P>0.05).Conclusion Patients at active AS phase have higher incidence of hepatic dysfunction than those at stable phase AS.NSAIDs,SSZ or MTX has no obvious influence on the liver function of AS patients.
What problem does this paper attempt to address?